-
Updated AskBio Leadership Structure Reflects Strategic Focus Posted on by TrueParallel in News&Uncategorized
-
AskBio Announces First Patient Dosed in Phase 1 / Phase 2 Trial of AB-1003 Gene Therapy for Limb-Girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9) Posted on by TrueParallel in News&Uncategorized
-
AskBio Vice President and Neurobiology Sector Lead Nathalie Cartier Honored with Ann B. Moser Award Posted on by TrueParallel in News
-
Selecta and AskBio Initiate First-in-Human Dose-Escalation Study to Evaluate ImmTOR in Gene Therapy Posted on by TrueParallel in News
-
AskBio Adds CNS Gene Therapy Programs in Parkinson’s Disease and Multiple System Atrophy Posted on by TrueParallel in News
-
Gene Therapy Leader Katherine High Joins AskBio as President, Therapeutics Posted on by TrueParallel in News
-
AskBio Applauds Commencement of Pfizer’s Pivotal Trial for Duchenne Muscular Dystrophy Posted on by TrueParallel in News
-
AskBio Welcomes Brain Neurotherapy Bio to Expand Clinical Pipeline for Neurodegenerative Diseases Posted on by TrueParallel in News
-
AskBio CSO Jude Samulski Named 2020 Business Person of the Year by Triangle Business Journal Posted on by TrueParallel in News
-
AskBio and Selecta Receive Orphan Drug Designation for MMA-101 to Treat Methylmalonic Acidemia Posted on by TrueParallel in News
